References
- Alford, K., & Vera, J. H. (2018). Cognitive impairment in people living with HIV in the ART era: A review. British Medical Bulletin, 127(1), 55–68. https://doi.org/10.1093/bmb/ldy019
- American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., Text Revision).
- Arentoft, A., Byrd, D., Monzones, J., Coulehan, K., Fuentes, A., Rosario, A., Miranda, C., Morgello, S., & Rivera Mindt, M. (2015). Socioeconomic status and neuropsychological functioning: Associations in an ethnically diverse HIV+ cohort. The Clinical Neuropsychologist, 29(2), 232–254. https://doi.org/10.1080/13854046.2015.1029974
- Bahorik, A. L., Leibowitz, A., Sterling, S. A., Travis, A., Weisner, C., & Satre, D. D. (2017). Patterns of marijuana use among psychiatry patients with depression and its impact on recovery. Journal of Affective Disorders, 213, 168–171. https://doi.org/10.1016/j.jad.2017.02.016
- Basso, M. R., & Bornstein, R. A. (2003). Effects of past noninjection drug abuse upon executive function and working memory in HIV infection. Journal of Clinical and Experimental Neuropsychology, 25(7), 893–903. https://doi.org/10.1076/jcen.25.7.893.16489
- Beck, A. T., Steer, R. A., & Brown, G. K. (1996). Beck depression inventory-II. San Antonio, 78(2), 490–498. https://doi.org/10.1037/t00742-000
- Becker, J. T., Kingsley, L., Mullen, J., Cohen, B., Martin, E., Miller, E. N., Ragin, A., Sacktor, N., Selnes, O. A., & Visscher, B. R. (2009). Vascular risk factors, HIV serostatus, and cognitive dysfunction in gay and bisexual men. Neurology, 73(16), 1292–1299. https://doi.org/10.1212/WNL.0b013e3181bd10e7
- Benedict, R. H. (1997). Brief visuospatial memory test-revised. PAR.
- Benedict, R. H., Schretlen, D., Groninger, L., & Brandt, J. (1998). Hopkins Verbal Learning Test–Revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist, 12(1), 43–55.
- Broyd, S. J., van Hell, H. H., Beale, C., Yücel, M., & Solowij, N. (2016). Acute and chronic effects of cannabinoids on human cognition—A systematic review. Biological Psychiatry, 79(7), 557–567. https://doi.org/10.1016/j.biopsych.2015.12.002
- Budney, A. J., & Moore, B. A. (2002). Development and consequences of cannabis dependence. The Journal of Clinical Pharmacology, 42(S1), 28S–33S. https://doi.org/10.1002/j.1552-4604.2002.tb06000.x
- Budney, A. J., Moore, B. A., Vandrey, R. G., & Hughes, J. R. (2003). The time course and significance of cannabis withdrawal. Journal of Abnormal Psychology, 112(3), 393–402. https://doi.org/10.1037/0021-843X.112.3.393
- Budney, A. J., Novy, P. L., & Hughes, J. R. (1999). Marijuana withdrawal among adults seeking treatment for marijuana dependence. Addiction, 94(9), 1311–1322. https://doi.org/10.1046/j.1360-0443.1999.94913114.x
- Byrd, D. A., Fellows, R. P., Morgello, S., Franklin, D., Heaton, R. K., Deutsch, R., Atkinson, J. H., Clifford, D. B., Collier, A. C., Marra, C. M., Gelman, B., McCutchan, J. A., Duarte, N. A., Simpson, D. M., McArthur, J., Grant, I., & CHARTER Group. (2011). Neurocognitive impact of substance use in HIV infection. Journal of Acquired Immune Deficiency Syndromes (1999), 58(2), 154–162. https://doi.org/10.1097/QAI.0b013e318229ba41
- Cargill, V. A., & Stone, V. E. (2005). HIV/AIDS: A minority health issue. Medical Clinics, 89(4), 895–912. https://doi.org/10.1016/j.mcna.2005.03.005
- Centers for Disease Control and Prevention. (2013). HIV among Hispanics/ Latinos in the United States and dependent areas, 2013.
- Chang, L., Cloak, C., Yakupov, R., & Ernst, T. (2006). Combined and independent effects of chronic marijuana use and HIV on brain metabolites. Journal of Neuroimmune Pharmacology, 1(1), 65–76. https://doi.org/10.1007/s11481-005-9005-z
- Chang, L., Ernst, T., Witt, M. D., Ames, N., Gaiefsky, M., & Miller, E. (2002). Relationships among brain metabolites, cognitive function, and viral loads in antiretroviral-naive HIV patients. Neuroimage, 17(3), 1638–1648. https://doi.org/10.1006/nimg.2002.1254
- Charron, C. B., & Leung, J. M. (2019). The safety and efficacy of marijuana in persons living with HIV. AIDS Reviews, 21(2), 84–92. https://doi.org/10.24875/AIDSRev.19000060
- Cherner, M., Letendre, S., Heaton, R. K., Durelle, J., Marquie-Beck, J., Gragg, B., Grant, I., & HIV Neurobehavioral research Center group. (2005). Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine. Neurology, 64(8), 1343–1347. https://doi.org/10.1212/01.WNL.0000158328.26897.0D
- Chu, C., & Selwyn, P. A. (2008). Current health disparities in HIV/AIDS. The AIDS Reader, 18(3), 144–146. 152-148, c143.
- Compton, W. M., Han, B., Jones, C. M., Blanco, C., & Hughes, A. (2016). Marijuana use and use disorders in adults in the USA, 2002–14: Analysis of annual cross-sectional surveys. The Lancet Psychiatry, 3(10), 954–964. https://doi.org/10.1016/S2215-0366(16)30208-5
- Cosentino, S., Manly, J. J., & Mungas, D. (2007). Do reading tests measure the same construct in multiethnic and multilingual persons. Journal of the International Neuropsychological Society, 13, 228–236. https://doi.org/10.1017/S1355617707070257
- Costiniuk, C. T., & Jenabian, M. A. (2019). Cannabinoids and inflammation: Implications for people living with HIV. AIDS (London, England), 33(15), 2273–2288. https://doi.org/10.1097/qad.0000000000002345
- Costiniuk, C. T., Saneei, Z., Salahuddin, S., Cox, J., Routy, J. P., Rueda, S., Abdallah, S. J., Jensen, D., Lebouché, B., Brouillette, M.-J., Klein, M., Szabo, J., Frenette, C., Giannakis, A., & Jenabian, M.-A. (2019). Cannabis consumption in people living with HIV: Reasons for use, secondary effects, and opportunities for health education. Cannabis and Cannabinoid Research, 4(3). https://doi.org/10.1089/can.2018.0068
- Crane, N. A., Schuster, R. M., Fusar-Poli, P., & Gonzalez, R. (2013). Effects of cannabis on neurocognitive functioning: Recent advances, neurodevelopmental influences, and sex differences. Neuropsychology Review, 23(2), 117–137. https://doi.org/10.1007/s11065-012-9222-1
- Cristiani, S. A., Pukay-Martin, N. D., & Bornstein, R. A. (2004). Marijuana use and cognitive function in HIV-infected people. Journal of Neuropsychiatry and Clinical Neurosciences, 16(3), 330–335. https://doi.org/10.1176/jnp.16.3.330
- Cysique, L. A., Letendre, S. L., Ake, C., Jin, H., Franklin, D. R., Gupta, S., Shi, C., Yu, X., Wu, Z., Abramson, I. S., Grant, I., & Heaton, R. K. (2010). Incidence and nature of cognitive decline over one year among HIV-infected former plasma donors in China. AIDS (London, England), 24(7), 983–990. https://doi.org/10.1097/QAD.0b013e32833336c8
- Cysique, L. A., Maruff, P., & Brew, B. J. (2004). Prevalence and pattern of neuropsychological impairment in human immunodeficiency virus-infected/acquired immunodeficiency syndrome (HIV/AIDS) patients across pre- and post-highly active antiretroviral therapy eras: A combined study of two cohorts. Journal of Neurovirology, 10(6), 350–357. https://doi.org/10.1080/13550280490521078
- Diehr, M. C., Cherner, M., Wolfson, T. J., Miller, S. W., Grant, I., Heaton, R. K., & HIV Neurobehavioral Research Center. (2003). The 50 and 100-item short forms of the Paced Auditory Serial Addition Task (PASAT): demographically corrected norms and comparisons with the full PASAT in normal and clinical samples. Journal of Clinical and Experimental Neuropsychology, 25(4), 571–585.
- Estrada, A. L. (2005). Health disparities among African-American and Hispanic drug injectors–HIV, AIDS, hepatitis B virus and hepatitis C virus: A review. AIDS, 19(Suppl 3), S47–S52. https://doi.org/10.1097/01.aids.0000192070.95819.7c
- Fazeli, P. L., Marceaux, J. C., Vance, D. E., Slater, L., & Long, C. A. (2011). Predictors of cognition in adults with HIV: Implications for nursing practice and research. The Journal of Neuroscience Nursing: Journal of the American Association of Neuroscience Nurses, 43(1), 36–50. https://doi.org/10.1097/JNN.0b013e3182029790
- Fergusson, D. M., & Boden, J. M. (2008). Cannabis use and later life outcomes. Addiction, 103(6), 969–976. https://doi.org/10.1111/j.1360-0443.2008.02221.x
- Ganzer, F., Broening, S., Kraft, S., Sack, P. M., & Thomasius, R. (2016). Weighing the evidence: A systematic review on long-term neurocognitive effects of cannabis use in abstinent adolescents and adults. Neuropsychology Review, 26(2), 186–222. https://doi.org/10.1007/s11065-016-9316-2
- Gollan, T. H., Montoya, R. I., & Werner, G. A. (2002). Semantic and letter fluency in Spanish-English bilinguals. Neuropsychology, 16(4), 562–576. https://doi.org/10.1037/0894-4105.16.4.562
- Gonzalez, R., Pacheco-Colon, I., Duperrouzel, J. C., & Hawes, S. W. (2017). Does cannabis use cause declines in neuropsychological functioning? A review of longitudinal studies. Journal of the International Neuropsychological Society, 23(9-10), 893–902. https://doi.org/10.1017/S1355617717000789
- Gonzalez, R., Schuster, R. M., Vassileva, J., & Martin, E. M. (2011). Impact of HIV and a history of marijuana dependence on procedural learning among individuals with a history of substance dependence. Journal of Clinical and Experimental Neuropsychology, 33(7), 735–752. https://doi.org/10.1080/13803395.2011.553584
- Goodkin, K., Wilkie, F. L., Concha, M., Hinkin, C. H., Symes, S., Baldewicz, T. T., Asthana, D., Fujimura, R. K., Lee, D., van Zuilen, M. H., Khamis, I., Shapshak, P., & Eisdorfer, C. (2001). Aging and neuro-AIDS conditions and the changing spectrum of HIV-1-associated morbidity and mortality. Journal of Clinical Epidemiology, 54(12), S35–S43. https://doi.org/10.1016/S0895-4356(01)00445-0
- Grant, I., Gonzalez, R., Carey, C. L., Natarajan, L., & Wolfson, T. (2003). Non-acute (residual) neurocognitive effects of cannabis use: A meta-analytic study. Journal of the International Neuropsychological Society, 9(5), 679–689. https://doi.org/10.1017/S1355617703950016
- Heaton, R. K., Clifford, D. B., Franklin, D. R., Woods, S. P., Ake, C., Vaida, F., Ellis, R. J., Letendre, S. L., Marcotte, T. D., Atkinson, J. H., Rivera-Mindt, M., Vigil, O. R., Taylor, M. J., Collier, A. C., Marra, C. M., Gelman, B. B., McArthur, J. C., Morgello, S., Simpson, D. M., … For the CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. CHARTER Study, 75(23), 2087–2096. https://doi.org/10.1212/wnl.0b013e318200d727
- Heaton, R. K., Franklin, Jr, D. R., Deutsch, R., Letendre, S., Ellis, R. J., Casaletto, K., Marquine, M. J., Woods, S. P., Vaida, F., Atkinson, J. H., Marcotte, T. D., McCutchan, J. A., Collier, A. C., Marra, C. M., Clifford, D. B., Gelman, B. B., Sacktor, N., Morgello, S., Simpson, D. M., … Teshome, M. (2015). Neurocognitive change in the era of HIV combination antiretroviral therapy: The longitudinal CHARTER study. Clinical Infectious Diseases, 60(3), 473–480. https://doi.org/10.1093/cid/ciu862
- Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., LeBlanc, S., Corkran, S. H., Duarte, N. A., Clifford, D. B., Woods, S. P., Collier, A. C., Marra, C. M., Morgello, S., Mindt, M. R., Taylor, M. J., Marcotte, T. D., Atkinson, J. H., Wolfson, T., Gelman, B. B., … HNRC Group. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16. https://doi.org/10.1007/s13365-010-0006-1
- Heaton, R., Miller, S. W., Taylor, M. J., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan Battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Psychological Assessment Resources.
- Hollingshead, A. B. (1975). Four factor index of social status. Yale University Press.
- Jacobus, J., Squeglia, L. M., Escobar, S., McKenna, B. M., Hernandez, M. M., Bagot, K. S., Taylor, C. T., & Huestis, M. A. (2017). Changes in marijuana use symptoms and emotional functioning over 28-days of monitored abstinence in adolescent marijuana users. Psychopharmacology (Berl), 234(23-24), 3431–3442.
- Jevtović, D., Vanovac, V., Veselinović, M., Salemović, D., Ranin, J., & Stefanova, E. (2009). The incidence of and risk factors for HIV-associated cognitive–motor complex among patients on HAART. Biomedicine & Pharmacotherapy, 63(8), 561–565. https://doi.org/10.1016/j.biopha.2008.09.015
- Kongs, S. K., Thompson, L. L., Iverson, G. L., & Heaton, R. K. (2000). WCST-64: Wisconsin Card Sorting Test-64 card version professional manual. PAR.
- Krefetz, D. G., Steer, R. A., Jermyn, R. T., & Condoluci, D. V. (2004). Screening HIV-infected patients with chronic pain for anxiety and mood disorders with the beck anxiety and depression inventory-fast screens for medical settings. Journal of Clinical Psychology in Medical Settings, 11(4), 283–289. https://doi.org/10.1023/B:JOCS.0000045348.28440.82
- Lev-Ran, S., Roerecke, M., Le Foll, B., George, T. P., McKenzie, K., & Rehm, J. (2014). The association between cannabis use and depression: A systematic review and meta analysis of longitudinal studies. Psychological Medicine, 44(4), 797–810. https://doi.org/10.1017/S0033291713001438
- Lorkiewicz, S. A., Ventura, A. S., Heeren, T. C., Winter, M. R., Walley, A. Y., Sullivan, M., Samet, J. H., & Saitz, R. (2018). Lifetime marijuana and alcohol use, and cognitive dysfunction in people with human immunodeficiency virus infection. Substance Abuse, 39(1), 116–123. https://doi.org/10.1080/08897077.2017.1391925
- Marcotte, T. D., Deutsch, R., McCutchan, J. A., Moore, D. J., Letendre, S., Ellis, R. J., Wallace, M. R., Heaton, R. K., & Grant, I. (2003). Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion. Archives of Neurology, 60(10), 1406–1412. https://doi.org/10.1001/archneur.60.10.1406
- Mariani, J. J., Brooks, D., Haney, M., & Levin, F. R. (2011). Quantification and comparison of marijuana smoking practices: Blunts, joints, and pipes. Drug and Alcohol Dependence, 113(2-3), 249–251. https://doi.org/10.1016/j.drugalcdep.2010.08.008
- Marquine, M. J., Heaton, A., Johnson, N., Rivera-Mindt, M., Cherner, M., Bloss, C., Hulgan, T., Umlauf, A., Moore, D. J., Fazeli, P., Morgello, S., Franklin, D., Letendre, S., Ellis, R., Collier, A. C., Marra, C. M., Clifford, D. B., … Heaton, R. K. (2018). Differences in neurocognitive impairment among HIV-infected Latinos in the United States. Journal of the International Neuropsychological Society, 24(2), 163–175. https://doi.org/10.1017/S1355617717000832
- McGinnis, K. A., Fine, M. J., Sharma, R. K., Skanderson, M., Wagner, J. H., Rodriguez-Barradas, M. C., Rabeneck, L., Justice, A. C., & Veterans Aging Cohort 3-Site Study (VACS 3). (2003). Understanding racial disparities in HIV using data from the veterans aging cohort 3-site study and VA administrative data. American Journal of Public Health, 93(10), 1728–1733. https://doi.org/10.2105/AJPH.93.10.1728
- Medina, K. L., Hanson, K. L., Schweinsburg, A. D., Cohen-Zion, M., Nagel, B. J., & Tapert, S. F. (2007). Neuropsychological functioning in adolescent marijuana users: Subtle deficits detectable after a month of abstinence. Journal of the International Neuropsychological Society, 13(5), 807–820. https://doi.org/10.1017/S1355617707071032
- Merlin, J. S., Bulls, H. W., Vucovich, L. A., Edelman, E. J., & Starrels, J. L. (2016). Pharmacologic and non-pharmacologic treatments for chronic pain in individuals with HIV: A systematic review. AIDS Care, 28(12), 1506–1515. https://doi.org/10.1080/09540121.2016.1191612
- Mimiaga, M. J., Reisner, S. L., Grasso, C., Crane, H. M., Safren, S. A., Kitahata, M. M., Schumacher, J. E., Mathews, W. C., & Mayer, K. H. (2013). Substance use among HIV-infected patients engaged in primary care in the United States: Findings from the centers for AIDS research network of integrated clinical systems cohort. American Journal of Public Health, 103(8), 1457–1467. https://doi.org/10.2105/AJPH.2012.301162
- Montgomery, L., Bagot, K., Brown, J. L., & Haeny, A. M. (2019). The association between marijuana use and HIV continuum of care outcomes: A systematic review. Current HIV/AIDS Reports, 16(1), 17–28. https://doi.org/10.1007/s11904-019-00422-z
- Morgello, S., Mahboob, R., Yakoushina, T., Khan, S., & Hague, K. (2002). Autopsy findings in a human immunodeficiency virus–infected population over 2 decades: Influences of gender, ethnicity, risk factors, and time. Archives of Pathology & Laboratory Medicine, 126(2), 182–190. https://doi.org/10.1043/0003-9985
- Norman, L. R., & Basso, M. (2015). An update of the review of neuropsychological consequences of HIV and substance abuse: A literature review and implications for treatment and future research. Current Drug Abuse Reviews, 8(1), 50–71. https://doi.org/10.2174/1874473708666150309124820
- Okafor, C. N., Plankey, M. W., Li, M., Chen, X., Surkan, P. J., Shoptaw, S., Martin, E., Cohen, R., Sacktor, N., & Cook, R. L. (2019). Association of marijuana use with changes in cognitive processing speed and flexibility for 17 years in HIV-seropositive and HIV-seronegative men. Substance Use & Misuse, 54(4), 525–537. https://doi.org/10.1080/10826084.2018.1495736
- Pacek, L. R., Towe, S. L., Hobkirk, A. L., Nash, D., & Goodwin, R. D. (2018). Frequency of cannabis use and medical cannabis use among persons living With HIV in the United States: Findings from a nationally representative sample. AIDS Education and Prevention, 30(2), 169–181. https://doi.org/10.1521/aeap.2018.30.2.169
- Park, J. Y., & Wu, L. T. (2017). Prevalence, reasons, perceived effects, and correlates of medical marijuana use: A review. Drug and Alcohol Dependence, 177, 1–13. https://doi.org/10.1016/j.drugalcdep.2017.03.009
- Pope, H. G., Gruber, A. J., Hudson, J. I., Huestis, M. A., & Yurgelun-Todd, D. (2001). Neuropsychological performance in long-term cannabis users. Archives of General Psychiatry, 58(10), 909–915. https://doi.org/10.1001/archpsyc.58.10.909
- Prentiss, D., Power, R., Balmas, G., Tzuang, G., & Israelski, D. M. (2004). Patterns of marijuana use among patients with HIV/AIDS followed in a public health care setting. JAIDS Journal of Acquired Immune Deficiency Syndromes, 35(1), 38–45. https://doi.org/10.1097/00126334-200401010-00005
- Rivera Mindt, M. R., Byrd, D., Ryan, E. L., Robbins, R., Monzones, J., Arentoft, A., Germano, K. K., Morgello, S., & Henniger, D. E. (2008). Characterization and sociocultural predictors of neuropsychological test performance in HIV+ Hispanic individuals. Cultural Diversity and Ethnic Minority Psychology, 14(4), 315–325. https://doi.org/10.1037/a0012615
- Rivera Mindt, M. R., Miranda, C., Arentoft, A., Byrd, D., Monzones, J., Fuentes, A., Arias, F., Rentería, M. A., Rosario, A., & Morgello, S. (2014). Aging and HIV/AIDS: Neurocognitive implications for older HIV-positive Latina/o adults. Behavioral Medicine, 40(3), 116–123. https://doi.org/10.1080/08964289.2014.914464
- Rubin, L. H., & Maki, P. M. (2019). HIV, depression, and cognitive impairment in the era of effective antiretroviral therapy. Current HIV/AIDS Reports, 16(1), 82–95. https://doi.org/10.1007/s11904-019-00421-0
- Sandoval, T. C., Gollan, T. H., Ferreira, V. S., & Salmon, D. P. (2010). What causes the bilingual disadvantage in verbal fluency? The dual-task analogy. Bilingualism: Language and Cognition, 13(2), 231–252. https://doi.org/10.1017/S1366728909990514
- Sattler, C., Toro, P., Schönknecht, P., & Schröder, J. (2012). Cognitive activity, education and socioeconomic status as preventive factors for mild cognitive impairment and Alzheimer’s disease. Psychiatry Research, 196(1), 90–95. https://doi.org/10.1016/j.psychres.2011.11.012
- Schouten, J., Cinque, P., Gisslen, M., Reiss, P., & Portegies, P. (2011). HIV-1 infection and cognitive impairment in the cART era: A review. Aids, 25(5), 561–575. https://doi.org/10.1097/QAD.0b013e3283437f9a
- Schreiner, A. M., & Dunn, M. E. (2012). Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: A meta-analysis. Experimental and Clinical Psychopharmacology, 20(5), 420–429. https://doi.org/10.1037/a0029117
- Stephens, R. S., Roffman, R. A., & Simpson, E. E. (1993). Adult marijuana users seeking treatment. Journal of Consulting and Clinical Psychology, 61(6), 1100.
- Thames, A. D., Kuhn, T. P., Williamson, T. J., Jones, J. D., Mahmood, Z., & Hammond, A. (2017). Marijuana effects on changes in brain structure and cognitive function among HIV+ and HIV− adults. Drug and Alcohol Dependence, 170, 120–127. https://doi.org/10.1016/j.drugalcdep.2016.11.007
- Thames, A. D., Mahmood, Z., Burggren, A. C., Karimian, A., & Kuhn, T. (2016). Combined effects of HIV and marijuana use on neurocognitive functioning and immune status. AIDS Care, 28(5), 628–632. https://doi.org/10.1080/09540121.2015.1124983
- Turner, B. J., Cunningham, W. E., Duan, N., Andersen, R. M., Shapiro, M. F., Bozzette, S. A., Nakazono, T., Morton, S., Crystal, S., St Clair, P., Stein, M., & Zierler, S. (2000). Delayed medical care after diagnosis in a US national probability sample of persons infected with human immunodeficiency virus. Archives of Internal Medicine, 160(17), 2614–2622. https://doi.org/10.1001/archinte.160.17.2614
- Vance, D. E., Woodley, R. A., & BurrageJrJ. R. (2007). Predictors of cognitive ability in adults aging with HIV: A pilot study. Clinical Gerontologist, 30(3), 83–101. https://doi.org/10.1300/J018v30n03_07
- Vaughan, A. S., Rosenberg, E., Shouse, R. L., & Sullivan, P. S. (2014). Connecting race and place: A county-level analysis of white, black, and Hispanic HIV prevalence, poverty, and level of urbanization. American Journal of Public Health, 104(7), e77–e84. https://doi.org/10.2105/AJPH.2014.301997
- Wechsler, D. (1997). Wechsler adult intelligence scale (3rd ed.). The Psychological Corporation.
- West, S. G., Cham, H., Thoemmes, F., Renneberg, B., Schulze, J., & Weiler, M. (2014). Propensity scores as a basis for equating groups: Basic principles and application in clinical treatment outcome research. Journal of Consulting and Clinical Psychology, 82(5), 906–919. https://doi.org/10.1037/a0036387
- Wilkinson, G. S. (1993). Wide range achievement test 3—administration manual. Jastak Associates, Inc.
- World Health Organization. (1994). Composite international diagnostic interview (CIDI) researcher’s manual (Version 1.1, 1994); Arlington, VA, US: American Psychiatric Association.
- Wu, A. W., Revicki, D. A., Jacobson, D., & Malitz, F. E. (1997). Evidence for reliability, validity and usefulness of the medical outcomes study HIV health survey (MOS-HIV). Quality of Life Research, 6(6), 481–493. https://doi.org/10.1023/A:1018451930750
- Wu, A. W., Rubin, H. R., Mathews, W. C., WareJrJ. E., Brysk, L. T., Hardy, W. D., Bozzette, S. A., Spector, S. A., & Richman, D. D. (1991). A health status questionnaire using 30 items from the medical outcomes study. Medical Care, 29(8), 786–798. https://doi.org/10.1097/00005650-199108000-00011
- Wu, L. T., Zhu, H., & Swartz, M. S. (2016). Trends in cannabis use disorders among racial/ethnic population groups in the United States. Drug and Alcohol Dependence, 165, 181–190. https://doi.org/10.1016/j.drugalcdep.2016.06.002
- Zvolensky, M. J., Bernstein, A., Sachs-Ericsson, N., Schmidt, N. B., Buckner, J. D., & Bonn-Miller, M. O. (2006). Lifetime associations between cannabis, use, abuse, and dependence and panic attacks in a representative sample. Journal of Psychiatric Research, 40(6), 477–486. https://doi.org/10.1016/j.jpsychires.2005.09.005